Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints
Background: Beta lactam group of antibiotics are one among the most widely used against enterobacterales. There has been an escalation of resistance among cephalosporins, and carbapenems in the recent days. Evaluation of resistance rates and careful selection of drugs based on Minimum Inhibitory Con...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Krishna Vishwa Vidyapeeth (Deemed to be University), Karad
2024-07-01
|
Series: | Journal of Krishna Institute of Medical Sciences University |
Subjects: | |
Online Access: | https://www.jkimsu.com/jkimsu-vol13no3/JKIMSU,%20Vol.%2013,%20No.%203,%20July-September%202024%20Page%2060-70.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832572536448090112 |
---|---|
author | Uma BM Neelesh Naik Rama N.K |
author_facet | Uma BM Neelesh Naik Rama N.K |
author_sort | Uma BM |
collection | DOAJ |
description | Background: Beta lactam group of antibiotics are one among the most widely used against enterobacterales. There has been an escalation of resistance among cephalosporins, and carbapenems in the recent days. Evaluation of resistance rates and careful selection of drugs based on Minimum Inhibitory Concentration (MIC) aids in effective therapy of infections caused by these resistant strains. Aim and Objectives: To determine the resistance rates of beta lactam antibiotics among enterobacterales, to analyse the relative extent of resistance and susceptibility based on their MIC, relative to their breakpoints, and also to determine MIC 50 and 90. Material and Methods: Study was conducted in a tertiary care hospital in rural Bengaluru from June 2022 to May 2023. A total of 733 clinical isolates from all samples were included in the study. Identification and antimicrobial susceptibility testing was done by VITEK-2 Compact automated system. Results: Based on analysis of MIC among urine samples, resistance rates of 88% for ampicillin, 71% for cefixime and 69% for ceftriaxone was seen. Among other samples 71%,61% and 57% resistance was seen to cefuroxime, ceftriaxone and amoxclav respectively. Least resistance was seen to meropenem (13%) cefoperazone sulbactam (17%) and imipenem (19%). Cefoperazone sulbactam and carbapenems had better susceptibility with MIC 50 less than the susceptible breakpoint. MIC 90 of piperacillin tazobactum and ceftazidime were well above the resistant breakpoint. Conclusion: Understanding the MIC and analysis of susceptibility and resistance of antibiotics will help in rational selection of antibiotics, which may serve as an aid in abating the development of resistant strains. It would be prudent to spare the drugs with MIC 90 above the resistant breakpoint from being included in the empirical panel and should be watchful while using third generation cephalosporins for uncomplicated infections |
format | Article |
id | doaj-art-3e5cf29364c545a18a94cae355c0183a |
institution | Kabale University |
issn | 2231-4261 |
language | English |
publishDate | 2024-07-01 |
publisher | Krishna Vishwa Vidyapeeth (Deemed to be University), Karad |
record_format | Article |
series | Journal of Krishna Institute of Medical Sciences University |
spelling | doaj-art-3e5cf29364c545a18a94cae355c0183a2025-02-02T09:11:32ZengKrishna Vishwa Vidyapeeth (Deemed to be University), KaradJournal of Krishna Institute of Medical Sciences University2231-42612024-07-011336070Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpointsUma BM0Neelesh Naik1 Rama N.K2Department of Microbiology, PES University, Institute of Medical Sciences and Research, Bengaluru- 560100 (Karnataka), IndiaDepartment of Microbiology, MVJ Medical College and Research Hospital Bengaluru-562114 (Karnataka) IndiaDepartment of Microbiology, MVJ Medical College and Research Hospital Bengaluru-562114 (Karnataka) IndiaBackground: Beta lactam group of antibiotics are one among the most widely used against enterobacterales. There has been an escalation of resistance among cephalosporins, and carbapenems in the recent days. Evaluation of resistance rates and careful selection of drugs based on Minimum Inhibitory Concentration (MIC) aids in effective therapy of infections caused by these resistant strains. Aim and Objectives: To determine the resistance rates of beta lactam antibiotics among enterobacterales, to analyse the relative extent of resistance and susceptibility based on their MIC, relative to their breakpoints, and also to determine MIC 50 and 90. Material and Methods: Study was conducted in a tertiary care hospital in rural Bengaluru from June 2022 to May 2023. A total of 733 clinical isolates from all samples were included in the study. Identification and antimicrobial susceptibility testing was done by VITEK-2 Compact automated system. Results: Based on analysis of MIC among urine samples, resistance rates of 88% for ampicillin, 71% for cefixime and 69% for ceftriaxone was seen. Among other samples 71%,61% and 57% resistance was seen to cefuroxime, ceftriaxone and amoxclav respectively. Least resistance was seen to meropenem (13%) cefoperazone sulbactam (17%) and imipenem (19%). Cefoperazone sulbactam and carbapenems had better susceptibility with MIC 50 less than the susceptible breakpoint. MIC 90 of piperacillin tazobactum and ceftazidime were well above the resistant breakpoint. Conclusion: Understanding the MIC and analysis of susceptibility and resistance of antibiotics will help in rational selection of antibiotics, which may serve as an aid in abating the development of resistant strains. It would be prudent to spare the drugs with MIC 90 above the resistant breakpoint from being included in the empirical panel and should be watchful while using third generation cephalosporins for uncomplicated infectionshttps://www.jkimsu.com/jkimsu-vol13no3/JKIMSU,%20Vol.%2013,%20No.%203,%20July-September%202024%20Page%2060-70.pdfbeta lactamsenterobacteralesminimum inhibitory concentrationbreakpoint |
spellingShingle | Uma BM Neelesh Naik Rama N.K Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints Journal of Krishna Institute of Medical Sciences University beta lactams enterobacterales minimum inhibitory concentration breakpoint |
title | Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints |
title_full | Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints |
title_fullStr | Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints |
title_full_unstemmed | Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints |
title_short | Evaluation of resistance rates of enterobacterales to beta-lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints |
title_sort | evaluation of resistance rates of enterobacterales to beta lactam drugs and interpretation of their minimum inhibitory concentrations relative to clinical breakpoints |
topic | beta lactams enterobacterales minimum inhibitory concentration breakpoint |
url | https://www.jkimsu.com/jkimsu-vol13no3/JKIMSU,%20Vol.%2013,%20No.%203,%20July-September%202024%20Page%2060-70.pdf |
work_keys_str_mv | AT umabm evaluationofresistanceratesofenterobacteralestobetalactamdrugsandinterpretationoftheirminimuminhibitoryconcentrationsrelativetoclinicalbreakpoints AT neeleshnaik evaluationofresistanceratesofenterobacteralestobetalactamdrugsandinterpretationoftheirminimuminhibitoryconcentrationsrelativetoclinicalbreakpoints AT ramank evaluationofresistanceratesofenterobacteralestobetalactamdrugsandinterpretationoftheirminimuminhibitoryconcentrationsrelativetoclinicalbreakpoints |